NCT00433615 - Clinical Study of R744 to Predialysis Patients | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Anemia in Pre-Dialysis Patients

Interventions

DRUG

R744

100μg(s.c./i.v.)/4 week for 8 weeks, then 25\~400μg(s.c./i.v.)/4 week for 40 weeks

DRUG

R744

150μg(s.c./i.v.)/4 week for 8 weeks, then 25\~400μg(s.c./i.v.)/4 week for 40 weeks

Trial Locations (6)

Chugoku/Shikoku region, Chugoku/Shikoku

Chubu region, Chūbu

Hokkaido/Tohoku region, Hokkaido/Tohoku

Kanto/Koshinetsu region, Kanto/Koshinetsu

Kinki/Hokuriku region, Kinki/Hokuriku

Kyusyu region, Kyusyu